文献速递腹部MR

离体MRI兼容定位装置对切除肝脏标本病灶的影像-病理对照研究

Radiologic-pathologic correlation of lesions in resected liver specimens with an ex vivo MRI-compatible localization device.
PubMed 文献 · Eur Radiol · 2022-07-21

这项前瞻性可行性研究纳入2018年2月至2019年1月接受治愈性部分肝切除术的成人患者,术中使用钆塞酸二钠,将切除肝脏标本固定于MRI兼容的病灶定位装置中行高分辨率3D T1WI和3D T2WI成像,以影像坐标引导病理切片,评估影像-病理共定位的成功率。结果显示57个影像学识别的病灶中52个(91%)经该装置病理学确认,其中5个(10%)肉眼检查 initially 未识别但经MRI引导定位后组织学确认,1个病灶肉眼识别但MRI未显示。作者认为该离体MRI兼容切片装置为小(<1 cm)肝脏病灶的影像-病理对照提供了可靠方法,可在临床实践环境中实施。

要点

  • 离体MRI兼容定位装置可实现肝脏病灶影像-病理共定位,52/57(91%)影像识别病灶经病理确认。
  • 38个(67%)病灶<1 cm,其中5个(10%)肉眼未识别但经MRI引导定位后组织学确认。
  • 术中给予钆塞酸二钠后离体标本数小时MRI仍呈良好强化和图像质量。

核心结论

  • 成功证明使用离体MRI兼容切片装置进行影像引导共定位和组织学特征分析的临床方法可行,该装置为小(<1 cm)肝脏病灶的影像-病理对照提供可靠方法,可在临床实践环境中实施并用于未来肝脏病灶特征研究。

研究设计与样本

  • 前瞻性可行性研究,2018年2月至2019年1月纳入接受治愈性部分肝切除术的成人患者,共10例受试者(肝转移瘤8例、原发性胆道黏液性囊性肿瘤1例、肝腺瘤病1例),术中使用钆塞酸二钠,切除肝脏标本固定于MRI兼容丙烯酸病灶定位装置(27×14×14 cm³,含切片通道和硅胶3D基质),使用单通道正交头线圈行高分辨率3D T1加权快速扰相梯度回波和3D T2加权快速自旋回波成像,以影像病灶坐标引导病理切片,所有病灶均行最终组织病理诊断。

关键影像表现/征象

  • 共识别并切取57个病灶,其中38个(67%)<1 cm;52/57(91%)影像学识别病灶经装置病理学识别,5个(10%)病灶肉眼检查 initially 未识别但经MRI引导定位后组织学确认,1个病灶肉眼识别但MRI未显示;术中给予钆塞酸二钠后离体MRI图像数小时仍显示强化且图像质量良好。

临床应用与阅片要点

  • 作者认为该离体MRI兼容切片装置为小(<1 cm)肝脏病灶的影像-病理对照提供可靠方法,可在临床实践环境中实施并用于未来肝脏病灶特征研究;术中给予钆塞酸二钠后离体标本数小时MRI仍呈良好强化和图像质量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Liver lesion characterization is limited by the lack of an established gold standard for precise correlation of radiologic characteristics with their histologic features. The objective of this study was to demonstrate the feasibility of using an ex vivo MRI-compatible sectioning device for radiologic-pathologic co-localization of lesions in resected liver specimens.

METHODS: In this prospective feasibility study, adults undergoing curative partial hepatectomy from February 2018 to January 2019 were enrolled. Gadoxetic acid was administered intraoperatively prior to hepatic vascular inflow ligation. Liver specimens were stabilized in an MRI-compatible acrylic lesion localization device (27 × 14 × 14 cm3) featuring slicing channels and a silicone gel 3D matrix. High-resolution 3D T1-weighted fast spoiled gradient echo and 3D T2-weighted fast-spin-echo images were acquired using a single channel quadrature head coil. Radiologic lesion coordinates guided pathologic sectioning. A final histopathologic diagnosis was prepared for all lesions. The proportion of successfully co-localized lesions was determined.

RESULTS: A total of 57 lesions were identified radiologically and sectioned in liver specimens from 10 participants with liver metastases (n = 8), primary biliary mucinous cystic neoplasm (n = 1), and hepatic adenomatosis (n = 1). Of these, 38 lesions (67%) were < 1 cm. Overall, 52/57 (91%) of radiologically identified lesions were identified pathologically using the device. Of these, 5 lesions (10%) were not initially identified on gross examination but were confirmed histologically using MRI-guided localization. One lesion was identified grossly but not on MRI.

CONCLUSIONS: We successfully demonstrated the feasibility of a clinical method for image-guided co-localization and histological characterization of liver lesions using an ex vivo MRI-compatible sectioning device.

KEY POINTS: • The ex vivo MRI-compatible sectioning device provides a reliable method for radiologic-pathologic correlation of small (< 1 cm) liver lesions in human liver specimens. • The sectioning method can be feasibly implemented within a clinical practice setting and used in future efforts to study liver lesion characterization. • Intraoperative administration of gadoxetic acid results in enhancement in ex vivo MRI images of liver specimens hours later with excellent image quality.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Rendell, Winslow, Colgan, et al. Radiologic-pathologic correlation of lesions in resected liver specimens with an ex vivo MRI-compatible localization device. Eur Radiol. 2022. PMID: 35864349. doi:10.1007/s00330-022-08990-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。